Merrimack Pharmaceuticals
MACK
#8017
Rank
A$0.35 B
Marketcap
$24.06
Share price
0.00%
Change (1 day)
6.14%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -$0.17

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.17. In 2022 the company made an earnings per share (EPS) of -$0.17 an increase over its 2021 EPS that were of -$0.29.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.17-5.52%
2022-$0.17-38.89%
2021-$0.29-25%
2020-$0.38-81.54%
2019-$2.07-56.95%
2018-$4.80-108.5%
2017$56.46-390.35%
2016-$19.45-7.35%
2015-$20.9965%
2014-$12.72-39.39%
2013-$20.99-54.01%
2012-$45.63-53.71%
2011-$98.5940.37%
2010-$70.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.06-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.34 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.54 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.01 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.97 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA